Abstract:The p53 tumor suppressor gene plays a key role in prevention of tumor formation through transcriptional dependent and independent mechanisms. Transcriptional-dependent mechanisms are mainly mediated by p53 regulation of downstream targets, leading to growth arrest and apoptosis. Mutational inactivation of the p53 gene is detected in more than 50% of human cancers. Mutation of p53 renders cancer cells more resistant to current cancer therapies due to lack of p53-mediated apoptosis. Extensive studies have been conducted to identify small molecules that manipulate p53, including restoration of mutant p53 conformation to wild-type, disruption of murine double minute-2 (Mdm2)-p53 binding to increase p53 level and inhibition of Mdm2 E3 ubiquitin ligase activity to prevent p53 degradation. Another approach was to identify and validate "drugable" target(s) in p53 signaling pathways that modulate p53-induced apoptosis. We profiled a p53 temperature-sensitive lung cancer cell model with the Affymetrix human HG-U133 GeneChip, covering the entire human transcriptome. We identified thousands of unique genes that were either induced or repressed in response to p53-induced apoptosis. A follow-up study characterized a p53-repressed gene, SAK, a polo-like kinase (PLK) family member, as an appealing cancer drug target. Snk/Plk-akin kinase (SAK) silencing via small interfering RNA (siRNA) induced apoptosis, whereas SAK overexpression attenuated p53-induced apoptosis. Thus, SAK repression by p53 contributes to p53-induced apoptosis. Future work is directed at determining the normal cell response to SAK silencing. If a therapeutic window is obtained, a SAK inhibitor identified from high throughput screening (HTS) could serve as a lead compound for development of a novel class of apoptosis-inducing anticancer drugs.

Dominant suppressor genes of p53-induced apoptosis in

Dominant suppressor genes of p53-induced apoptosis in Drosophila melanogaster

Change From Promotion To Inhibition On Apoptosis In Hepatoma Cells Transferred Wild-Type P53 Gene

Inhibition of Nonsense-Mediated Decay Rescues Functional P53β/γ Isoforms in MDM2-amplified Cancers

Transcription activity is required for p53-dependent tumor suppression

Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter site

Evaluating the Influence of a G-Quadruplex Prone Sequence on the Transactivation Potential by Wild-Type and/or Mutant P53 Family Proteins through a Yeast-Based Functional Assay

Mitogen-Activated Protein Kinase Phosphatase 2 : A Novel Transcription Target of P 53 in Apoptosis

Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway

Integrative multiomic approaches reveal ZMAT3 and p21 as conserved hubs in the p53 tumor suppression network

A positive feedback mechanism in the transcriptional activation of Apaf-1 by p53 and the coactivator Zac-1

Overexpression of DRAM enhances p53-dependent apoptosis

A Naturally Occurring 4-Bp Deletion in the Intron 4 of P53 Creates a Spectrum of Novel P53 Isoforms with Anti-Apoptosis Function

Abstract P10: p44, the Amino-terminal Lacking Isoform of p53, is Dispensable for Tumor Suppression but Regulates Male Fertility

P53 Transcriptional Activity is Essential for P53-Dependent Apoptosis Following DNA Damage

P53 and Its Downstream Proteins As Molecular Targets of Cancer

Identification and Characterization of Genes Responsive to Apoptosis: Application of DNA Chip Technology and Mrna Differential Display.

Identification of p53-46F as a super p53 with an enhanced ability to induce p53-dependent apoptosis

HOPS/TMUB1 Enhances Apoptosis in TP53 Mutation-Independent Setting in Human Cancers

Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities

Mouse models to investigate in situ cell fate decisions induced by p53